Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, BrightSpring Health Services Inc’s stock clocked out at $10.27, down -2.84% from its previous closing price of $10.57. In other words, the price has decreased by -$2.84 from its previous closing price. On the day, 1.19 million shares were traded. BTSG stock price reached its highest trading level at $10.84 during the session, while it also had its lowest trading level at $10.18.
Ratios:
To gain a deeper understanding of BTSG’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 6.28 whereas as Long-Term Debt/Eq ratio is at 6.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, HSBC Securities on March 06, 2024, initiated with a Buy rating and assigned the stock a target price of $13.
On February 27, 2024, Deutsche Bank Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $11.50.
On February 20, 2024, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $15.Wells Fargo initiated its Overweight rating on February 20, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 15 ’24 when ROUSSEAU JON B bought 18,400 shares for $8.09 per share. The transaction valued at 148,856 led to the insider holds 369,763 shares of the business.
ROUSSEAU JON B bought 18,400 shares of BTSG for $148,856 on Mar 15 ’24. The insider now owns 1,025,636 shares after completing the transaction at $8.09 per share. On Mar 15 ’24, another insider, Mattingly James F Jr, who serves as the insider of the company, bought 6,080 shares for $8.26 each. As a result, the insider paid 50,221 and bolstered with 134,780 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 1758121344 and an Enterprise Value of 5443454464. Its current Enterprise Value per Revenue stands at 0.617 whereas that against EBITDA is 15.574.
Stock Price History:
Over the past 52 weeks, BTSG has reached a high of $12.14, while it has fallen to a 52-week low of $7.85. The 50-Day Moving Average of the stock is 2.92%, while the 200-Day Moving Average is calculated to be 1.76%.
Shares Statistics:
It appears that BTSG traded 2.79M shares on average per day over the past three months and 1124770 shares per day over the past ten days. A total of 171.19M shares are outstanding, with a floating share count of 52.76M. Insiders hold about 69.18% of the company’s shares, while institutions hold 0.01% stake in the company. Shares short for BTSG as of 1711584000 were 15308532 with a Short Ratio of 5.49, compared to 1709164800 on 9233485. Therefore, it implies a Short% of Shares Outstanding of 15308532 and a Short% of Float of 29.549998.
Earnings Estimates
The current rating of BrightSpring Health Services Inc (BTSG) reflects the combined expertise of 8 analysts actively engaged in assessing its market performance.On average, analysts expect EPS of $0.07 for the current quarter, with a high estimate of $0.2 and a low estimate of $0, while EPS last year was –$. The consensus estimate for the next quarter is $0.18, with high estimates of $0.36 and low estimates of $0.12.
Analysts are recommending an EPS of between $1.25 and $0.35 for the fiscal current year, implying an average EPS of $0.59. EPS for the following year is $0.8, with 10 analysts recommending between $1.48 and $0.52.
Revenue Estimates
A total of 11 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $9.57B, while the lowest revenue estimate was $9.36B, resulting in an average revenue estimate of $9.44B. In the same quarter a year ago, actual revenue was $8.83B, up 7.00% from the average estimate. Based on 11 analysts’ estimates, the company’s revenue will be $10.25B in the next fiscal year. The high estimate is $10.49B and the low estimate is $10.13B. The average revenue growth estimate for next year is up 8.60% from the average revenue estimate for this year.
